Release Notes: Version 20220113
About this release
This release (version 20220113) provides the latest updates to the Canadian Clinical Drug Data Set in English and French. A separate InfoScribe location for the French supporting documents, including the French Release Notes, can be found here.
There is no change to the Technical Specification or the Editorial Guidelines.
The Canadian Clinical Drug Data Set is available for browsing and download via the Infoway Terminology Gateway.
Supporting general information can be found on Infoway Canadian Clinical Drug Data Set InfoCentral page.
General Notes
The following files are available as full release files within this version:
- Manufactured Product,
- Non-proprietary Therapeutic Product,
- Therapeutic Moiety,
- Manufactured Product-Non-proprietary Therapeutic Product-Therapeutic Product Relationship, in English (MP-NTP-TM Relationship),
- Manufactured Product-Non-proprietary Therapeutic Product-Therapeutic Product Relationship, in French (Relation PM-PTC-FT),
- Special Groupings,
- Coded Attribute, and
- Device Non-proprietary Therapeutic Product.
The "Full" release contains one entry for every concept that has ever been released and new content added for that release. New content added for a specific release may at times include “Inactive” content.
NOTE: The “Delta" release which is intended to contain only those concepts that have been added or changed since the previous release will be considered for a future enhancement at a later date.
This release reflects additions and changes that have occurred in DPD since the last CCDD release.
Nonproprietary Therapeutic Product (NTP)
There are 2 new deprecated concept in this version resulting from changes in DPD.
ntp_code | ntp_formal_name | ntp_fr_description | Type of change | Replaced by ntp_code | Replaced by ntp_formal_name | Replaced by ntp_fr_description |
|---|---|---|---|---|---|---|
| 9000004 | epinephrine (epinephrine hydrochloride) 1 mg per mL nasal spray | épinéphrine (chlorhydrate d'épinéphrine) 1 mg par mL vaporisation nasale | Concept deprecated | 9014635 | epinephrine (epinephrine hydrochloride) 1 mg per mL cutaneous solution | épinéphrine (chlorhydrate d'épinéphrine) 1 mg par mL solution pour application cutanée |
| 9002965 | raltitrexed (raltitrexed disodium) 2 mg per vial powder for solution for injection | raltitrexed (raltitrexed disodique) 2 mg par fiole poudre pour solution injectable | Concept deprecated | 9014637 | raltitrexed 2 mg per vial powder for solution for injection | raltitrexed 2 mg par fiole poudre pour solution injectable |
Manufactured Product (MP)
There is 1 new deprecated concept in this version. The code for the corresponding MP needed to be changed due to additional presentations for the same DIN.
mp_code | mp_formal_name | mp_fr_description | Type of change | Replaced by mp_code | mp_formal_name | mp_fr_description |
|---|---|---|---|---|---|---|
| 02258595 | HUMIRA (adalimumab 40 mg per 0.8 mL solution for injection vial) ABBVIE CORPORATION | HUMIRA (adalimumab 40 mg par 0,8 mL solution injectable fiole) ABBVIE CORPORATION | Concept deprecated | 77701101 | HUMIRA (adalimumab 40 mg per 0.8 mL solution for injection vial) ABBVIE CORPORATION | HUMIRA (adalimumab 40 mg par 0,8 mL solution injectable fiole) ABBVIE CORPORATION |
Questions, Concerns, Changes
Questions and concerns and suggestions for future consideration are welcomed and should be sent by e-mail at [email protected]